Cargando…
Delivery of Chemotherapy Agents and Nucleic Acids with pH-Dependent Nanoparticles
With less than one percent of systemically injected nanoparticles accumulating in tumors, several novel approaches have been spurred to direct and release the therapy in or near tumors. One such approach depends on the acidic pH of the extracellular matrix and endosomes of the tumor. With an average...
Autores principales: | Leng, Qixin, Imtiyaz, Zuha, Woodle, Martin C., Mixson, A. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222096/ https://www.ncbi.nlm.nih.gov/pubmed/37242725 http://dx.doi.org/10.3390/pharmaceutics15051482 |
Ejemplares similares
-
pH-Sensitive Targeting of Tumors with Chemotherapy-Laden Nanoparticles: Progress and Challenges
por: Imtiyaz, Zuha, et al.
Publicado: (2022) -
Targeted Delivery of siRNA Therapeutics to Malignant Tumors
por: Leng, Qixin, et al.
Publicado: (2017) -
Marked increase in tumor transfection with a truncated branched polymer
por: Xu, Songhui, et al.
Publicado: (2021) -
The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges
por: He, Jiaxi, et al.
Publicado: (2020) -
Increased tumor distribution and expression of histidine-rich plasmid polyplexes
por: Leng, Qixin, et al.
Publicado: (2014)